In contrast, Chen et al. later quoted Le Douce and provided results that concur with our findings, showing that PHGDH mRNA and protein levels rise as AD pathology and symptoms worsen in 3xTg-AD and P301S tau transgenic mice (PS19) and human AD brains [122]. This evidence concerns the gene MAPT and Alzheimer disease.